These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19246001

  • 1. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
    Prudent R, Cochet C.
    Chem Biol; 2009 Feb 27; 16(2):112-20. PubMed ID: 19246001
    [Abstract] [Full Text] [Related]

  • 2. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
    Prudent R, Moucadel V, Laudet B, Barette C, Lafanechère L, Hasenknopf B, Li J, Bareyt S, Lacôte E, Thorimbert S, Malacria M, Gouzerh P, Cochet C.
    Chem Biol; 2008 Jul 21; 15(7):683-92. PubMed ID: 18635005
    [Abstract] [Full Text] [Related]

  • 3. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
    Nie Z, Perretta C, Erickson P, Margosiak S, Almassy R, Lu J, Averill A, Yager KM, Chu S.
    Bioorg Med Chem Lett; 2007 Aug 01; 17(15):4191-5. PubMed ID: 17540560
    [Abstract] [Full Text] [Related]

  • 4. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J, Brunstein E, Issinger OG, Niefind K.
    Chem Biol; 2008 Feb 01; 15(2):111-7. PubMed ID: 18291315
    [Abstract] [Full Text] [Related]

  • 5. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
    Battistutta R, Mazzorana M, Sarno S, Kazimierczuk Z, Zanotti G, Pinna LA.
    Chem Biol; 2005 Nov 01; 12(11):1211-9. PubMed ID: 16298300
    [Abstract] [Full Text] [Related]

  • 6. Protein kinase CK2 as a druggable target.
    Sarno S, Pinna LA.
    Mol Biosyst; 2008 Sep 01; 4(9):889-94. PubMed ID: 18704226
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
    Golub AG, Yakovenko OY, Bdzhola VG, Sapelkin VM, Zien P, Yarmoluk SM.
    J Med Chem; 2006 Nov 02; 49(22):6443-50. PubMed ID: 17064064
    [Abstract] [Full Text] [Related]

  • 8. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
    Bogoyevitch MA, Fairlie DP.
    Drug Discov Today; 2007 Aug 02; 12(15-16):622-33. PubMed ID: 17706543
    [Abstract] [Full Text] [Related]

  • 9. Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2.
    Prudent R, Sautel CF, Cochet C.
    Biochim Biophys Acta; 2010 Mar 02; 1804(3):493-8. PubMed ID: 19766740
    [Abstract] [Full Text] [Related]

  • 10. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.
    Yde CW, Ermakova I, Issinger OG, Niefind K.
    J Mol Biol; 2005 Mar 25; 347(2):399-414. PubMed ID: 15740749
    [Abstract] [Full Text] [Related]

  • 11. Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2.
    Gianoncelli A, Cozza G, Orzeszko A, Meggio F, Kazimierczuk Z, Pinna LA.
    Bioorg Med Chem; 2009 Oct 15; 17(20):7281-9. PubMed ID: 19748274
    [Abstract] [Full Text] [Related]

  • 12. Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors.
    Cozza G, Gianoncelli A, Bonvini P, Zorzi E, Pasquale R, Rosolen A, Pinna LA, Meggio F, Zagotto G, Moro S.
    ChemMedChem; 2011 Dec 09; 6(12):2273-86. PubMed ID: 21972104
    [Abstract] [Full Text] [Related]

  • 13. Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
    Hundsdörfer C, Hemmerling HJ, Götz C, Totzke F, Bednarski P, Le Borgne M, Jose J.
    Bioorg Med Chem; 2012 Apr 01; 20(7):2282-9. PubMed ID: 22377675
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
    Lolli G, Cozza G, Mazzorana M, Tibaldi E, Cesaro L, Donella-Deana A, Meggio F, Venerando A, Franchin C, Sarno S, Battistutta R, Pinna LA.
    Biochemistry; 2012 Aug 07; 51(31):6097-107. PubMed ID: 22794353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L, Turowec JP, Bretner M, Litchfield DW.
    Biochim Biophys Acta; 2013 Jul 07; 1834(7):1352-8. PubMed ID: 23416530
    [Abstract] [Full Text] [Related]

  • 19. New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
    López-Ramos M, Prudent R, Moucadel V, Sautel CF, Barette C, Lafanechère L, Mouawad L, Grierson D, Schmidt F, Florent JC, Filippakopoulos P, Bullock AN, Knapp S, Reiser JB, Cochet C.
    FASEB J; 2010 Sep 07; 24(9):3171-85. PubMed ID: 20400536
    [Abstract] [Full Text] [Related]

  • 20. Discovery and characterization of synthetic 4'-hydroxyflavones-New CK2 inhibitors from flavone family.
    Golub AG, Bdzhola VG, Ostrynska OV, Kyshenia IV, Sapelkin VM, Prykhod'ko AO, Kukharenko OP, Yarmoluk SM.
    Bioorg Med Chem; 2013 Nov 01; 21(21):6681-9. PubMed ID: 24011954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.